DENTSPLY SIRONA Statistics
Total Valuation
XRAY has a market cap or net worth of $6.29 billion. The enterprise value is $8.20 billion.
| Market Cap | 6.29B |
| Enterprise Value | 8.20B |
Important Dates
The next confirmed earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | Mar 27, 2024 |
Share Statistics
XRAY has 207.36 million shares outstanding. The number of shares has decreased by -1.62% in one year.
| Shares Outstanding | 207.36M |
| Shares Change (YoY) | -1.62% |
| Shares Change (QoQ) | -0.90% |
| Owned by Insiders (%) | 0.37% |
| Owned by Institutions (%) | 105.67% |
| Float | 205.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 14.35 |
| PS Ratio | 1.59 |
| Forward PS | 1.54 |
| PB Ratio | 1.91 |
| P/FCF Ratio | 26.78 |
| PEG Ratio | 1.53 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.94, with an EV/FCF ratio of 34.90.
| EV / Earnings | n/a |
| EV / Sales | 2.07 |
| EV / EBITDA | 32.94 |
| EV / EBIT | n/a |
| EV / FCF | 34.90 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.39 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 9.01 |
| Debt / FCF | 9.54 |
| Interest Coverage | -1.16 |
Financial Efficiency
Return on equity (ROE) is -3.80% and return on invested capital (ROIC) is -1.54%.
| Return on Equity (ROE) | -3.80% |
| Return on Assets (ROA) | -1.80% |
| Return on Capital (ROIC) | -1.54% |
| Revenue Per Employee | $264,333 |
| Profits Per Employee | -$8,800 |
| Employee Count | 15,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 3.00 |
Taxes
| Income Tax | -43.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.92% in the last 52 weeks. The beta is 0.99, so XRAY's price volatility has been similar to the market average.
| Beta (1Y) | 0.99 |
| 52-Week Price Change | -25.92% |
| 50-Day Moving Average | 32.59 |
| 200-Day Moving Average | 34.20 |
| Relative Strength Index (RSI) | 34.52 |
| Average Volume (30 Days) | 3,610,054 |
Short Selling Information
The latest short interest is 11.93 million, so 5.75% of the outstanding shares have been sold short.
| Short Interest | 11.93M |
| Short Previous Month | 10.46M |
| Short % of Shares Out | 5.75% |
| Short % of Float | 5.80% |
| Short Ratio (days to cover) | 4.11 |
Income Statement
In the last 12 months, XRAY had revenue of $3.97 billion and -$132.00 million in losses. Loss per share was -$0.62.
| Revenue | 3.97B |
| Gross Profit | 2.09B |
| Operating Income | -85.00M |
| Pretax Income | -175.00M |
| Net Income | -132.00M |
| EBITDA | 249.00M |
| EBIT | -94.00M |
| Loss Per Share | -$0.62 |
Balance Sheet
The company has $334.00 million in cash and $2.24 billion in debt, giving a net cash position of -$1.91 billion or -$9.21 per share.
| Cash & Cash Equivalents | 334.00M |
| Total Debt | 2.24B |
| Net Cash | -1.91B |
| Net Cash Per Share | -$9.21 |
| Equity / Book Value | 3.29B |
| Book Value Per Share | 15.88 |
| Working Capital | 548.00M |
Cash Flow
In the last 12 months, operating cash flow was $377.00 million and capital expenditures -$142.00 million, giving a free cash flow of $235.00 million.
| Operating Cash Flow | 377.00M |
| Capital Expenditures | -142.00M |
| Free Cash Flow | 235.00M |
| FCF Per Share | $1.11 |
Margins
Gross margin is 52.61%, with operating and profit margins of -2.14% and -3.33%.
| Gross Margin | 52.61% |
| Operating Margin | -2.14% |
| Pretax Margin | -4.41% |
| Profit Margin | -3.33% |
| EBITDA Margin | 6.28% |
| EBIT Margin | -2.37% |
| FCF Margin | 5.93% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 2.11%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 2.11% |
| Dividend Growth (YoY) | 12.62% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | 1.62% |
| Shareholder Yield | 3.73% |
| Earnings Yield | -2.10% |
| FCF Yield | 3.73% |
Analyst Forecast
The average price target for XRAY is $39.13, which is 28.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $39.13 |
| Price Target Difference | 28.93% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 4.00% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 18, 2006. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 18, 2006 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
XRAY has an Altman Z-Score of 1.55 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.55 |
| Piotroski F-Score | 5 |